These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 38649936

  • 1. Clinical significance of urinary inflammatory biomarkers in patients with IgA nephropathy.
    Yoon SY, Kim JS, Jung SW, Kim YG, Moon JY, Lee SH, Yim SV, Hwang HS, Jeong K.
    BMC Nephrol; 2024 Apr 22; 25(1):142. PubMed ID: 38649936
    [Abstract] [Full Text] [Related]

  • 2. Accuracy of Urinary Epidermal Growth Factor to Creatinine Ratio to Predict 24-Hour Urine Epidermal Growth Factor and Interstitial Kidney Fibrosis in Patients with IgA Nephropathy.
    Segarra A, Carnicer C, Jatem E, Martin M, Molina M, Perich C, Martinez C.
    Clin Lab; 2019 Jun 01; 65(6):. PubMed ID: 31232037
    [Abstract] [Full Text] [Related]

  • 3. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar 01; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 4. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
    Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Economidou D, Leontsini M, Memmos D.
    Nephrology (Carlton); 2009 Sep 01; 14(6):613-20. PubMed ID: 19143943
    [Abstract] [Full Text] [Related]

  • 5. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017 Sep 01; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 6. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.
    Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG.
    Korean J Intern Med; 2014 May 01; 29(3):334-40. PubMed ID: 24851068
    [Abstract] [Full Text] [Related]

  • 7. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy.
    Ranieri E, Gesualdo L, Petrarulo F, Schena FP.
    Kidney Int; 1996 Dec 01; 50(6):1990-2001. PubMed ID: 8943482
    [Abstract] [Full Text] [Related]

  • 8. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.
    Niu X, Zhang S, Shao C, Guo Z, Wu J, Tao J, Zheng K, Ye W, Cai G, Sun W, Li M.
    PeerJ; 2023 Dec 01; 11():e15125. PubMed ID: 37065697
    [Abstract] [Full Text] [Related]

  • 9. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.
    Liu LL, Jiang Y, Wang LN, Liu N.
    Clin Exp Immunol; 2012 Aug 01; 169(2):148-55. PubMed ID: 22774989
    [Abstract] [Full Text] [Related]

  • 10. Urinary C4d and progression of kidney disease in IgA vasculitis.
    Yu G, Zhao J, Wang M, Chen Y, Feng S, Li B, Wang C, Wang Y, Jiang H, Chen J.
    Nephrol Dial Transplant; 2024 Sep 27; 39(10):1642-1648. PubMed ID: 38373839
    [Abstract] [Full Text] [Related]

  • 11. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):947-955. PubMed ID: 27026518
    [Abstract] [Full Text] [Related]

  • 12. Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy.
    Ji FP, Wen L, Zhang YP, Liu EP, Wen JG.
    Int Urol Nephrol; 2022 Jun 06; 54(6):1287-1294. PubMed ID: 34585312
    [Abstract] [Full Text] [Related]

  • 13. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
    Yang JYC, Sarwal RD, Fervenza FC, Sarwal MM, Lafayette RA.
    Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510053
    [Abstract] [Full Text] [Related]

  • 14. The role of urine IgG in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis.
    Xu X, Huang X, Chen Y, Li J, Shen M, Hou Y, Lin X, Lin Q, Liu X, Bao K, Wang L, Yang H, Liu L, Zou C.
    Int Urol Nephrol; 2022 Feb 10; 54(2):323-330. PubMed ID: 33871780
    [Abstract] [Full Text] [Related]

  • 15. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
    Neuhaus J, Bauer F, Fitzner C, Hilgers RD, Seibert F, Babel N, Doevelaar A, Eitner F, Floege J, Rauen T, Westhoff TH.
    Kidney Blood Press Res; 2018 Feb 10; 43(5):1563-1572. PubMed ID: 30347407
    [Abstract] [Full Text] [Related]

  • 16. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.
    Torres DD, Rossini M, Manno C, Mattace-Raso F, D'Altri C, Ranieri E, Pontrelli P, Grandaliano G, Gesualdo L, Schena FP.
    Kidney Int; 2008 Feb 10; 73(3):327-33. PubMed ID: 17943082
    [Abstract] [Full Text] [Related]

  • 17. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R, Asanuma K, Kodama F, Akiba-Takagi M, Nagai-Hosoe Y, Seki T, Takeda Y, Ohsawa I, Mano S, Matsuoka K, Kurosawa H, Ogasawara S, Hirayama Y, Sekine S, Horikoshi S, Hara M, Tomino Y.
    Clin J Am Soc Nephrol; 2012 Sep 10; 7(9):1385-93. PubMed ID: 22700887
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
    Yoon SY, Kim JS, Jung SW, Kim YG, Hwang HS, Moon JY, Lee SH, Seo JW, Seok J, Tae D, Jeong K.
    Sci Rep; 2023 Oct 11; 13(1):17201. PubMed ID: 37821628
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity.
    Li G, Wu W, Zhang X, Huang Y, Wen Y, Li X, Gao R.
    BMC Nephrol; 2018 Nov 14; 19(1):326. PubMed ID: 30428849
    [Abstract] [Full Text] [Related]

  • 20. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H, Allegri L, Suzuki Y, Hall S, Moldoveanu Z, Wyatt RJ, Novak J, Julian BA.
    Dis Markers; 2016 Nov 14; 2016():7806438. PubMed ID: 27647947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.